Variant report
Variant | nsv963664 |
---|---|
Chromosome Location | chr2:96240105-96244648 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:13)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:4)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:13 , 50 per page) page:
1
No data |
No data |
(count:4 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-TRIM43-5 | chr2:96242981-96243209 | NONHSAT072499 |
2 | lnc-TRIM43-5 | chr2:96243917-96243932 | NONHSAT072499 |
3 | lnc-TRIM43-5 | chr2:96240647-96241052 | NONHSAT072499 |
4 | lnc-TRIM43-5 | chr2:96241343-96241421 | NONHSAT072499 |
No data |
No data |
Variant related genes | Relation type |
---|---|
TRIM51JP | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs554242165 | chr2:96240143-96240144 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs567500501 | chr2:96240205-96240206 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs536433080 | chr2:96240290-96240291 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs556496020 | chr2:96240355-96240356 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs553316559 | chr2:96240363-96240364 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs76333649 | chr2:96240368-96240369 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs371275736 | chr2:96240408-96240409 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs200181516 | chr2:96240417-96240418 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs115700567 | chr2:96240419-96240420 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs145328859 | chr2:96240424-96240425 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs544738206 | chr2:96240432-96240433 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs543522826 | chr2:96240498-96240499 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs553978931 | chr2:96240565-96240566 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs572160500 | chr2:96240577-96240578 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs113398319 | chr2:96240592-96240593 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs530247173 | chr2:96240665-96240666 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
17 | rs540400675 | chr2:96240685-96240686 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
18 | rs560416955 | chr2:96240686-96240687 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
19 | rs532627591 | chr2:96240742-96240743 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
20 | rs201721546 | chr2:96240792-96240793 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
21 | rs552588508 | chr2:96240811-96240812 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
22 | rs564943796 | chr2:96240849-96240850 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
23 | rs530407062 | chr2:96240852-96240853 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
24 | rs113845160 | chr2:96240900-96240901 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
25 | rs567332665 | chr2:96240923-96240924 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
26 | rs192547335 | chr2:96240944-96240945 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
27 | rs185065052 | chr2:96240964-96240965 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
28 | rs566781078 | chr2:96241006-96241007 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
29 | rs147981600 | chr2:96241012-96241013 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
30 | rs558570794 | chr2:96241049-96241050 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
31 | rs1974909 | chr2:96241051-96241052 | Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs564753004 | chr2:96241057-96241058 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs145886511 | chr2:96241058-96241059 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs532533941 | chr2:96241071-96241072 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs544239382 | chr2:96241248-96241249 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs574546023 | chr2:96241262-96241263 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs188354747 | chr2:96241317-96241318 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs560357298 | chr2:96241363-96241364 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
39 | rs577021359 | chr2:96241422-96241423 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs546506465 | chr2:96241446-96241447 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs75032531 | chr2:96241488-96241489 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs565315964 | chr2:96241581-96241582 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs370786157 | chr2:96241586-96241587 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs193180957 | chr2:96241644-96241645 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs550276093 | chr2:96241647-96241648 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs560966876 | chr2:96241658-96241659 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs7577991 | chr2:96241688-96241689 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs546707637 | chr2:96241764-96241765 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs184677221 | chr2:96241798-96241799 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs570831609 | chr2:96243017-96243018 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 17483303 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Breast cancer | 16272173 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Lung cancer | 18438408 | CNVD |
Mowat-Wilson syndrome | 21572526 | CNVD |
Disorders of sex development | 21048976 | CNVD |
epilepsy | 18472482 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Neuroblastoma | 18574593 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Breast cancer | 21509527 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intellectual disability | 22045946 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Epilepsy | 22083797 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:96239400-96241800 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
2 | chr2:96239600-96241200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
3 | chr2:96240600-96241400 | Enhancers | Brain Cingulate Gyrus | brain |
4 | chr2:96243400-96245000 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
5 | chr2:96244400-96244800 | Enhancers | HSMMtube | muscle |
6 | chr2:96244600-96245000 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |